Legis Daily

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

USA119th CongressHR-1492| House 
| Updated: 2/21/2025
Gregory F. Murphy

Gregory F. Murphy

Republican Representative

North Carolina

Cosponsors (66)
Diana Harshbarger (Republican)Adrian Smith (Republican)David Kustoff (Republican)Richard McCormick (Republican)Ashley Hinson (Republican)Andy Harris (Republican)Rick W. Allen (Republican)Neal P. Dunn (Republican)Zachary Nunn (Republican)Vince Fong (Republican)Michael Baumgartner (Republican)Mike Carey (Republican)Claudia Tenney (Republican)Mariannette Miller-Meeks (Republican)Beth Van Duyne (Republican)Aaron Bean (Republican)Andrew Ogles (Republican)David Rouzer (Republican)Scott H. Peters (Democratic)Brad Knott (Republican)Donald G. Davis (Democratic)Earl L. "Buddy" Carter (Republican)Nathaniel Moran (Republican)Michael A. Rulli (Republican)Brian Jack (Republican)J. French Hill (Republican)Rudy Yakym (Republican)Lloyd Smucker (Republican)Thomas H. Kean (Republican)Mike Flood (Republican)Jefferson Shreve (Republican)Carol D. Miller (Republican)Mike Kelly (Republican)Richard Hudson (Republican)Mike Kennedy (Republican)Kat Cammack (Republican)Cliff Bentz (Republican)W. Gregory Steube (Republican)James Comer (Republican)Scott Fitzgerald (Republican)August Pfluger (Republican)Mike Haridopolos (Republican)Pat Harrigan (Republican)Mark E. Amodei (Republican)Gabe Evans (Republican)Russell Fry (Republican)Addison P. McDowell (Republican)Dan Crenshaw (Republican)Brian K. Fitzpatrick (Republican)Bill Huizenga (Republican)Max L. Miller (Republican)Juan Ciscomani (Republican)Robert E. Latta (Republican)John J. McGuire (Republican)Kevin Hern (Republican)Randy K. Sr. Weber (Republican)Robert P. Bresnahan (Republican)Erin Houchin (Republican)Julie Fedorchak (Republican)Michelle Fischbach (Republican)Troy Balderson (Republican)Tim Moore (Republican)Bryan Steil (Republican)Nicole Malliotakis (Republican)Craig A. Goldman (Republican)Vern Buchanan (Republican)

Ways and Means Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill proposes to amend Title XI of the Social Security Act, specifically targeting the Drug Price Negotiation Program . Its primary goal is to equalize the negotiation period for small-molecule drugs with that of biologic candidates. Currently, small-molecule drugs are subject to price negotiation after 7 years, while biologics have an 11-year period. This legislation would change the negotiation period for small-molecule drugs from 7 years to 11 years , aligning it with the timeline for biologics. The amendment would take effect as if it had been included in the original enactment of Public Law 117-169, ensuring retroactive application.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 118-7174
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Feb 21, 2025
Introduced in House
Feb 21, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • Bill from Previous Congress

    HR 118-7174
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.


  • February 21, 2025
    Introduced in House


  • February 21, 2025
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Health

Health care costs and insuranceMedicarePrescription drugs

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

USA119th CongressHR-1492| House 
| Updated: 2/21/2025
This bill proposes to amend Title XI of the Social Security Act, specifically targeting the Drug Price Negotiation Program . Its primary goal is to equalize the negotiation period for small-molecule drugs with that of biologic candidates. Currently, small-molecule drugs are subject to price negotiation after 7 years, while biologics have an 11-year period. This legislation would change the negotiation period for small-molecule drugs from 7 years to 11 years , aligning it with the timeline for biologics. The amendment would take effect as if it had been included in the original enactment of Public Law 117-169, ensuring retroactive application.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 118-7174
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Feb 21, 2025
Introduced in House
Feb 21, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • Bill from Previous Congress

    HR 118-7174
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.


  • February 21, 2025
    Introduced in House


  • February 21, 2025
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Gregory F. Murphy

Gregory F. Murphy

Republican Representative

North Carolina

Cosponsors (66)
Diana Harshbarger (Republican)Adrian Smith (Republican)David Kustoff (Republican)Richard McCormick (Republican)Ashley Hinson (Republican)Andy Harris (Republican)Rick W. Allen (Republican)Neal P. Dunn (Republican)Zachary Nunn (Republican)Vince Fong (Republican)Michael Baumgartner (Republican)Mike Carey (Republican)Claudia Tenney (Republican)Mariannette Miller-Meeks (Republican)Beth Van Duyne (Republican)Aaron Bean (Republican)Andrew Ogles (Republican)David Rouzer (Republican)Scott H. Peters (Democratic)Brad Knott (Republican)Donald G. Davis (Democratic)Earl L. "Buddy" Carter (Republican)Nathaniel Moran (Republican)Michael A. Rulli (Republican)Brian Jack (Republican)J. French Hill (Republican)Rudy Yakym (Republican)Lloyd Smucker (Republican)Thomas H. Kean (Republican)Mike Flood (Republican)Jefferson Shreve (Republican)Carol D. Miller (Republican)Mike Kelly (Republican)Richard Hudson (Republican)Mike Kennedy (Republican)Kat Cammack (Republican)Cliff Bentz (Republican)W. Gregory Steube (Republican)James Comer (Republican)Scott Fitzgerald (Republican)August Pfluger (Republican)Mike Haridopolos (Republican)Pat Harrigan (Republican)Mark E. Amodei (Republican)Gabe Evans (Republican)Russell Fry (Republican)Addison P. McDowell (Republican)Dan Crenshaw (Republican)Brian K. Fitzpatrick (Republican)Bill Huizenga (Republican)Max L. Miller (Republican)Juan Ciscomani (Republican)Robert E. Latta (Republican)John J. McGuire (Republican)Kevin Hern (Republican)Randy K. Sr. Weber (Republican)Robert P. Bresnahan (Republican)Erin Houchin (Republican)Julie Fedorchak (Republican)Michelle Fischbach (Republican)Troy Balderson (Republican)Tim Moore (Republican)Bryan Steil (Republican)Nicole Malliotakis (Republican)Craig A. Goldman (Republican)Vern Buchanan (Republican)

Ways and Means Committee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Health care costs and insuranceMedicarePrescription drugs